284 related articles for article (PubMed ID: 36389140)
41. The Impact of Short-Chain Fatty Acids on Neonatal Regulatory T Cells.
Chun J; Toldi G
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145046
[TBL] [Abstract][Full Text] [Related]
42. Dual role of microbiota-derived short-chain fatty acids on host and pathogen.
Mirzaei R; Dehkhodaie E; Bouzari B; Rahimi M; Gholestani A; Hosseini-Fard SR; Keyvani H; Teimoori A; Karampoor S
Biomed Pharmacother; 2022 Jan; 145():112352. PubMed ID: 34840032
[TBL] [Abstract][Full Text] [Related]
43. Supplementation with SCFAs Re-Establishes Microbiota Composition and Attenuates Hyperalgesia and Pain in a Mouse Model of NTG-Induced Migraine.
Lanza M; Filippone A; Casili G; Giuffrè L; Scuderi SA; Paterniti I; Campolo M; Cuzzocrea S; Esposito E
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563235
[TBL] [Abstract][Full Text] [Related]
44. Physiological Role of Gut Microbiota for Maintaining Human Health.
Andoh A
Digestion; 2016; 93(3):176-81. PubMed ID: 26859303
[TBL] [Abstract][Full Text] [Related]
45. Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol.
Dugas LR; Lie L; Plange-Rhule J; Bedu-Addo K; Bovet P; Lambert EV; Forrester TE; Luke A; Gilbert JA; Layden BT
BMC Public Health; 2018 Aug; 18(1):978. PubMed ID: 30081857
[TBL] [Abstract][Full Text] [Related]
46. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.
Mathewson ND; Jenq R; Mathew AV; Koenigsknecht M; Hanash A; Toubai T; Oravecz-Wilson K; Wu SR; Sun Y; Rossi C; Fujiwara H; Byun J; Shono Y; Lindemans C; Calafiore M; Schmidt TM; Honda K; Young VB; Pennathur S; van den Brink M; Reddy P
Nat Immunol; 2016 May; 17(5):505-513. PubMed ID: 26998764
[TBL] [Abstract][Full Text] [Related]
47. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
[TBL] [Abstract][Full Text] [Related]
48. Protective effect of the "food-microorganism-SCFAs" axis on colorectal cancer: from basic research to practical application.
Shuwen H; Miao D; Quan Q; Wei W; Zhongshan Z; Chun Z; Xi Y
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2169-2197. PubMed ID: 31401674
[TBL] [Abstract][Full Text] [Related]
49. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
Peng K; Xia S; Xiao S; Yu Q
J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
[TBL] [Abstract][Full Text] [Related]
50. Effects of short chain fatty acids on metabolic and inflammatory processes in human health.
Campos-Perez W; Martinez-Lopez E
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 May; 1866(5):158900. PubMed ID: 33571672
[TBL] [Abstract][Full Text] [Related]
51. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
52. A High Salt Diet Modulates the Gut Microbiota and Short Chain Fatty Acids Production in a Salt-Sensitive Hypertension Rat Model.
Bier A; Braun T; Khasbab R; Di Segni A; Grossman E; Haberman Y; Leibowitz A
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30142973
[TBL] [Abstract][Full Text] [Related]
53. Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls.
Olsson A; Gustavsen S; Nguyen TD; Nyman M; Langkilde AR; Hansen TH; Sellebjerg F; Oturai AB; Bach Søndergaard H
Front Immunol; 2021; 12():661493. PubMed ID: 34025661
[TBL] [Abstract][Full Text] [Related]
54. Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease.
Kotlyarov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563159
[TBL] [Abstract][Full Text] [Related]
55. The roles of microbial products in the development of colorectal cancer: a review.
Fang Y; Yan C; Zhao Q; Xu J; Liu Z; Gao J; Zhu H; Dai Z; Wang D; Tang D
Bioengineered; 2021 Dec; 12(1):720-735. PubMed ID: 33618627
[TBL] [Abstract][Full Text] [Related]
56. Sodium butyrate reduces endoplasmic reticulum stress by modulating CHOP and empowers favorable anti-inflammatory adipose tissue immune-metabolism in HFD fed mice model of obesity.
Kushwaha V; Rai P; Varshney S; Gupta S; Khandelwal N; Kumar D; Nilkanth Gaikwad A
Food Chem (Oxf); 2022 Jul; 4():100079. PubMed ID: 35415672
[TBL] [Abstract][Full Text] [Related]
57. Diet as a modifiable factor in tumorigenesis: Focus on microbiome-derived bile acid metabolites and short-chain fatty acids.
Ahmad F; Saha P; Singh V; Wahid M; Mandal RK; Nath Mishra B; Fagoonee S; Haque S
Food Chem; 2023 Jun; 410():135320. PubMed ID: 36610090
[TBL] [Abstract][Full Text] [Related]
58. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
[TBL] [Abstract][Full Text] [Related]
59. Microbiota-Derived Short-Chain Fatty Acids Modulate Expression of
Luethy PM; Huynh S; Ribardo DA; Winter SE; Parker CT; Hendrixson DR
mBio; 2017 May; 8(3):. PubMed ID: 28487428
[No Abstract] [Full Text] [Related]
60. Butyrate-induced IL-22 expression in fish macrophages contributes to bacterial clearance.
Zhang J; Wang W; Liang S; Shao R; Shi W; Gudmundsson GH; Bergman P; Ai Q; Mai K; Wan M
Fish Shellfish Immunol; 2023 Feb; 133():108545. PubMed ID: 36642352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
